Molecular BiologyFrontiers in PharmacologyPeer-reviewed
Profiling crystal engineered ligands for targeting treatment resistant androgen receptors
Avan N Colah, Charles Izuchukwu Ezekiel, Sára Ferková…·William A. Ricke
This study develops and evaluates crystal-engineered ligands (CBs) for targeting treatment-resistant androgen receptors in prostate cancer, showing their potential as novel therapeutic agents.
DOI 10.3389/fphar.2026.1813002